share_log

江苏亚虹医药科技股份有限公司自愿披露关于APL-2302临床试验申请获得FDA批准的公告

Jiangsu Yahong Pharmaceutical Technology Co., Ltd. voluntarily disclosed the announcement that the APL-2302 clinical trial application was approved by the FDA

SZSI ·  Oct 24, 2024 12:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more